We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$106B
AUM Growth
-$22.4B
Cap. Flow
+$44.2B
Cap. Flow %
41.6%
Top 10 Hldgs %
42.41%
Holding
4,108
New
765
Increased
1,315
Reduced
1,298
Closed
285

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.85B
2
EQIX icon
Equinix
EQIX
+$2.31B
3
TSLA icon
Tesla
TSLA
+$2.3B
4
SNDK
SANDISK CORP
SNDK
+$1.87B
5
TRLA
TRULIA INC (DEL)
TRLA
+$1.64B

Sector Composition

Rank Sector Weight
1 Technology 4.77%
2 Financials 3.07%
3 Industrials 1.75%
4 Healthcare 1.67%
5 Materials 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFSL icon
2676
TFS Financial
TFSL
$4.93B
$3.78K ﹤0.01%
265
-7,196
-96% -$96.7K
ESNT icon
2677
Essent Group
ESNT
$6.23B
$3.78K ﹤0.01%
188
+143
+318% +$2.91K
CYNI
2678
DELISTED
CYAN INC COM
CYNI
$3.77K ﹤0.01%
936
+587
+168% +$2.35K
VSB
2679
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
$3.77K ﹤0.01%
634
-155
-20% -$951
RMBS icon
2680
Rambus
RMBS
$10.8B
$3.76K ﹤0.01%
+263
New +$3.25K
PTP
2681
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
$3.76K ﹤0.01%
+58
New +$3.65K
JBSS icon
2682
John B. Sanfilippo & Son
JBSS
$1.01B
$3.76K ﹤0.01%
142
+134
+1,675% +$3.33K
STRZA
2683
DELISTED
Starz - Series A
STRZA
$3.75K ﹤0.01%
126
-26,344
-100% -$804K
FORR icon
2684
Forrester Research
FORR
$224M
$3.75K ﹤0.01%
+99
New +$3.62K
CLAR icon
2685
Clarus
CLAR
$145M
$3.75K ﹤0.01%
335
+319
+1,994% +$3.55K
ABCO
2686
DELISTED
Advisory Board Co
ABCO
$3.73K ﹤0.01%
72
-93
-56% -$5.03K
NLY icon
2687
CALL
Annaly Capital Management
NLY
$17.6B
$3.73K ﹤0.01%
+370
New +$17.1K
CLCT
2688
DELISTED
Collectors Universe
CLCT
$3.7K ﹤0.01%
189
CBPX
2689
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$3.7K ﹤0.01%
+240
New +$3.93K
AERI
2690
DELISTED
Aerie Pharmaceuticals
AERI
$3.69K ﹤0.01%
149
+136
+1,046% +$2.36K
FRM
2691
DELISTED
FURMANITE CORPORATION COM
FRM
$3.69K ﹤0.01%
+317
New +$3.33K
INWK
2692
DELISTED
InnerWorkings, Inc.
INWK
$3.69K ﹤0.01%
+434
New +$3.24K
FCFS icon
2693
FirstCash
FCFS
$9.14B
$3.69K ﹤0.01%
+64
New +$3.31K
MANH icon
2694
Manhattan Associates
MANH
$11.7B
$3.68K ﹤0.01%
107
+30
+39% +$990
SGM
2695
DELISTED
Stonegate Mortgage Corporation
SGM
$3.67K ﹤0.01%
+263
New +$3.66K
ETRM
2696
DELISTED
EnteroMedics Inc.
ETRM
$3.66K ﹤0.01%
2
CHFN
2697
DELISTED
Charter Financial Corp
CHFN
$3.65K ﹤0.01%
329
+302
+1,119% +$3.27K
LUX
2698
DELISTED
Luxottica Group
LUX
$3.65K ﹤0.01%
63
IRWD icon
2699
Ironwood Pharmaceuticals
IRWD
$674M
$3.65K ﹤0.01%
284
+185
+187% +$2.01K
CALM icon
2700
Cal-Maine
CALM
$3.87B
$3.64K ﹤0.01%
98
+74
+308% +$2.43K

Similar funds

BNP Paribas Financial Markets's Q2 2014 Portfolio in Review

As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.

  • BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
  • BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
  • BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
  • BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
  • BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
  • BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
  • BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.